Evidence map›Paper›PMID 32785690›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

Tubular Secretory Clearance Is Associated With Whole-Body Insulin Clearance.

Matthew P Huber, Leila R Zelnick, Kristina M Utzschneider, Steven E Kahn, Ian H de Boer, Bryan R Kestenbaum

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matthew P HuberUniversity of Washington, Department of Medicine, Seattle, Washington.
Leila R ZelnickKidney Research Institute, Seattle, Washington.
Kristina M UtzschneiderVA Puget Sound Health Care System, Seattle, Washington.
Steven E KahnVA Puget Sound Health Care System, Seattle, Washington.
Ian H de BoerKidney Research Institute, Seattle, Washington.
Bryan R KestenbaumKidney Research Institute, Seattle, Washington.
University of Washington · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Tomas Vaisar · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Tubular Secretion in Chronic Kidney DiseaseR01DK107931 · NIDDK · UNIVERSITY OF WASHINGTON · PI KESTENBAUM, BRYAN R · 2016 to 2019
$2.7M
Insulin Resistance in Chronic Kidney DiseaseR01DK087726 · NIDDK · UNIVERSITY OF WASHINGTON · PI DE BOER, IAN H · 2010 to 2013
$1.9M
Midcareer Investigator Award: Metabolic Complications of Chronic Kidney DiseaseK24DK103986 · NIDDK · UNIVERSITY OF WASHINGTON · PI KESTENBAUM, BRYAN R · 2016 to 2020
$637k
NIDDK NIH HHS K24 DK103986NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816NIDDK NIH HHS R01 DK087726NIDDK NIH HHS R01 DK107931
6 · The paper itself

Abstract

contextThe kidneys eliminate insulin via glomerular and peritubular mechanisms; consequently, the kidney contribution to insulin clearance may be underestimated by the glomerular filtration rate (GFR) alone.

objectiveTo determine associations of tubular secretory clearance with whole-body insulin clearance and sensitivity in a dedicated study of glucose and insulin metabolism. DESIGN, SETTING, AND

participantsWe performed an ancillary, cross-sectional study of tubular secretion in the Study of Glucose and Insulin in Renal Disease (SUGAR). Hyperinsulinemic-euglycemic clamps were performed in 57 nondiabetic persons with chronic kidney disease and 38 persons without kidney disease.

interventionWe measured plasma and 24-hour urine concentrations of endogenous solutes primarily eliminated by tubular secretion. Kidney clearances of secretory solutes were calculated as the amount of blood fully cleared of that solute per minute.

main outcome measuresWhole-body insulin clearance, insulin sensitivity.

resultsMean whole-body insulin clearance was 924 ± 228 mL/min. After adjustment for age, sex, Black race, fat and fat-free mass, each 20% lower estimated GFR was associated with a 13 mL/min lower insulin clearance (95% confidence interval [CI], 2-24 mL/min lower). Each 20% lower clearance of isovalerylglycine and xanthosine were associated with a 16 mL/min lower (95% CI, 5-26 mL/min lower) and 19 mL/min lower (95% CI, 7-31 mL/min lower) insulin clearance, respectively. Neither estimated GFR nor secretory solute clearances were associated with insulin sensitivity after adjustment.

conclusionsThese results highlight the importance of tubular secretory pathways to insulin elimination but suggest that kidney functions in aggregate contribute only modestly to systemic insulin clearance.

Indexed as

AgedCross-Sectional StudiesFemaleGlomerular Filtration RateGlucoseGlucose Clamp TechniqueHumansInsulinInsulin ResistanceKidney DiseasesKidney Function TestsKidney TubulesMaleMiddle AgedGlucoseInsulinhyperinsulinemic-euglycemic clampinsulin sensitivityisovalerylglycinetubular secretory clearancewhole-body insulin clearancexanthosine

Identifiers

PMID32785690
PMCPMC7500476
OpenAlexW3049070467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.